SCHEMBL17982137

SCHEMBL17982137

O=C(O)c1ncc2c(cnn2-c2ccccc2)c1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
HTT P42858 3/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
MITF O75030 1/20 0.44
S1PR4 O95977 1/20 0.44
ALDH1A1 P00352 1/20 0.44
THRB P10828 1/20 0.44
XBP1 P17861 1/20 0.44
S1PR1 P21453 1/20 0.44
PAX8 Q06710 1/20 0.44
NR3C1 P04150 1/20 0.44
MAPK1 P28482 2/20 0.42
PFKFB3 Q16875 1/20 0.42
TP53 P04637 1/20 0.41
KDM4E B2RXH2 3/20 0.41
POLB P06746 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NR4A3 Q92570 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17963452 0.85 TP53 (0.46) MAPTSMN1; SMN2HTTALDH1A1NR3C1
SCHEMBL17963178 0.81 NR3C1 (0.63) MAPTHTTNPC1RAB9AALDH1A1
SCHEMBL20413597 0.80 NPC1 (0.57) MAPTSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL20413783 0.78 ALDH1A1 (0.44) MAPTSMN1; SMN2HTTNPC1RAB9A
SCHEMBL17963138 0.77 NR3C1 (0.53) MAPTNPC1RAB9ANR3C1MEN1
SCHEMBL17963319 0.73 TP53 (0.47) MAPTSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL3465108 0.72 POLB (0.50) MAPTSMN1; SMN2MAPK1TP53POLB
SCHEMBL7012220 0.71 NR3C1 (0.68) MAPTSMN1; SMN2HTTNPC1RAB9A
SCHEMBL1269627 0.71 EGLN1 (0.58)
SCHEMBL17963401 0.71 NR3C1 (0.56) MAPTNPC1RAB9AALDH1A1NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10272074-B2 Inhibitors of glucocorticoid receptor translocation Sanford Burnham Prebys Medical Discovery Institute (US) 2019-04-30 US disclosed
US-20180207140-A1 Pyrazolopyrimidines as Inhibitors of Glucocorticoid Receptor Translocation Sanford Burnham Prebys Medical Discovery Institute 2018-07-26 US disclosed
WO-2016123392-A2 PYRAZOLOPYRIMIDINES AS INHIBITORS OF GLUCOCORTICOID RECEPTOR TRANSLOCATION SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2016-08-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180207140-A1 Pyrazolopyrimidines as Inhibitors of Glucocorticoid Receptor Translocation NR3C1, NR3C2, GRK3 MAPT 1843/4885SMN1; SMN2 4568/4885HTT 3354/4885
US-10272074-B2 Inhibitors of glucocorticoid receptor translocation NR3C1, NR3C2, GRK3 MAPT 2106/4885SMN1; SMN2 4638/4885HTT 3491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.